Semaglutide versus GLP-1 agonists. Effectiveness, safety, and quality of life in patients with diabetes mellitus 2. The SEVERAL study

Autor: Seijas-Amigo, José *, Salgado-Barreira, Ángel, Castelo-Domínguez, Rosana, Pereira-Pía, Mercedes, Rodríguez-Mañero, Moisés, González-Juanatey, José Ramón
Zdroj: In Farmacia Hospitalaria November-December 2022 46(6):372-379
Databáze: ScienceDirect